- Home
- MDGL vs SUZ Comparison
MDGL vs SUZ Comparison
Compare MDGL & SUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | SUZ |
|---|---|---|
| Founded | 2011 | 1924 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 10.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MDGL | SUZ |
|---|---|---|
| Price | $561.08 | $8.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $553.08 | N/A |
| AVG Volume (30 Days) | 317.0K | ★ 2.3M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 2.94% |
| EPS Growth | N/A | ★ 61.72 |
| EPS | N/A | ★ 0.99 |
| Revenue | $740,640,000.00 | ★ $9,603,137,110.00 |
| Revenue This Year | $436.04 | $7.22 |
| Revenue Next Year | $53.17 | $13.64 |
| P/E Ratio | ★ N/A | $9.10 |
| Revenue Growth | ★ 864.21 | 17.39 |
| 52 Week Low | $265.00 | $8.41 |
| 52 Week High | $605.00 | $10.86 |
Technical Indicators
Market Signals| Indicator | MDGL | SUZ |
|---|---|---|
| Relative Strength Index (RSI) | 55.21 | 44.52 |
| Support Level | $546.20 | $9.20 |
| Resistance Level | $589.67 | $9.53 |
| Average True Range (ATR) | 20.09 | 0.16 |
| MACD | -6.52 | -0.01 |
| Stochastic Oscillator | 24.57 | 22.67 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.